Endovascular and Neurosurgical Management of Acute lschemic Stroke

被引:1
作者
Singh, Jasmeet [1 ]
Thanh Ngoc Nguyen [1 ,2 ,3 ]
机构
[1] Boston Univ, Sch Med, Dept Neurol, Boston Med Ctr, Boston, MA 02118 USA
[2] Boston Univ, Sch Med, Dept Neurosurg, Boston Med Ctr, Boston, MA 02118 USA
[3] Boston Univ, Sch Med, Dept Radiol, Boston Med Ctr, Boston, MA 02118 USA
关键词
Acute ischemic stroke (AIS); Endovascular therapy; Stenting; Intra-arterial fibrinolysis; Mechanical thrombectomy; Recanalization; MERCI; Penumbra; MIDDLE-CEREBRAL-ARTERY; ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN-ACTIVATOR; LOCAL INTRAARTERIAL FIBRINOLYSIS; RANDOMIZED-TRIAL; DECOMPRESSIVE CRANIECTOMY; INTRAVENOUS THROMBOLYSIS; MECHANICAL THROMBECTOMY; CAROTID-ENDARTERECTOMY; MALIGNANT INFARCTION;
D O I
10.1016/j.emc.2012.06.002
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Acute ischemic stroke is recognized as the third leading cause of death in the United States; improved treatments for management are important to reduce disability and death. The standard of care of acute stroke therapy has been reperfusion/recanalization of the occluded vessels using pharmacologic management, endovascular management, or a combination approach. Significant improvements have been made in the management with the use of endovascular therapy. This article reviews the literature on the endovascular and neurosurgical management of patients presenting with acute ischemic stroke and presents current evidence-based guidelines for endovascular or neurosurgical interventions outlined for management of ischemic stroke.
引用
收藏
页码:695 / +
页数:19
相关论文
共 62 条
[1]   Intra-arterial Therapy for Acute Ischemic Stroke [J].
Abou-Chebl, Alex .
NEUROTHERAPEUTICS, 2011, 8 (03) :400-413
[2]   CLOTBUST: Design of a randomized trial of ultrasound-enhanced thrombolysis for acute ischemic stroke [J].
Alexandrov, AV ;
Wojner, AW ;
Grotta, JC .
JOURNAL OF NEUROIMAGING, 2004, 14 (02) :108-112
[3]   Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator [J].
Alexandrov, AV ;
Grotta, JC .
NEUROLOGY, 2002, 59 (06) :862-867
[4]  
[Anonymous], CLIN NEUROL NEUROSUR
[5]   Reasons why few patients with acute stroke receive tissue plasminogen activator [J].
Bambauer, Kara Z. ;
Johnston, S. Claiborne ;
Bambauer, Derek E. ;
Zivin, Justin A. .
ARCHIVES OF NEUROLOGY, 2006, 63 (05) :661-664
[6]   Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility [J].
Barber, PA ;
Zhang, J ;
Demchuk, AM ;
Hill, MD ;
Buchan, AM .
NEUROLOGY, 2001, 56 (08) :1015-1020
[8]   The interventional management of stroke (IMS) II study [J].
Broderick, Joseph P. .
STROKE, 2007, 38 (07) :2127-2135
[9]   PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke [J].
del Zoppo, GJ ;
Higashida, RT ;
Furlan, AJ ;
Pessin, MS ;
Rowley, HA ;
Gent, M .
STROKE, 1998, 29 (01) :4-11
[10]   RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE THROMBOTIC AND EMBOLIC STROKE [J].
DELZOPPO, GJ ;
POECK, K ;
PESSIN, MS ;
WOLPERT, SM ;
FURLAN, AJ ;
FERBERT, A ;
ALBERTS, MJ ;
ZIVIN, JA ;
WECHSLER, L ;
BUSSE, O ;
GREENLEE, R ;
BRASS, L ;
MOHR, JP ;
FELDMANN, E ;
HACKE, W ;
KASE, CS ;
BILLER, J ;
GRESS, D ;
OTIS, SM .
ANNALS OF NEUROLOGY, 1992, 32 (01) :78-86